Apogee Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	May '25 May 14, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	2,300	2,578	1,342	-
Market Cap Growth	-40.94%	92.14%	-	-
Enterprise Value	1,648	1,836	919	-
Last Close Price	39.74	45.30	27.94	-
PB Ratio	3.44	3.60	3.53	-
P/TBV Ratio	3.44	3.60	3.53	-
Debt / Equity Ratio	0.02	0.02	0.01	-
Quick Ratio	15.73	18.40	19.30	15.22
Current Ratio	15.82	18.55	19.38	15.24
Return on Equity (ROE)	-27.85%	-33.22%	-32.18%	-
Return on Assets (ROA)	-19.65%	-23.46%	-21.00%	-
Return on Capital (ROIC)	-20.30%	-24.41%	-22.18%	-
Earnings Yield	-8.86%	-7.07%	-6.26%	-
FCF Yield	-8.33%	-6.69%	-5.58%	-
Buyback Yield / Dilution	-57.55%	-120.72%	-915.57%	-

Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q